Nagata Y, Yamamoto Y, Niki E
Research Center for Advanced Science and Technology, University of Tokyo, Japan.
Arch Biochem Biophys. 1996 May 1;329(1):24-30. doi: 10.1006/abbi.1996.0187.
In order to elucidate the reason why phosphatidylcholine hydroperoxide is unstable in human plasma, 1-palmitoyl-2-linoleoylphosphatidylcholine hydroperoxide (PLPC-OOH) was incubated aerobically in human plasma at 37 degrees C, and its decomposition products were measured. The major product was the corresponding alcohol (PLPC-OH) and this reduction probably occurred by an enzymatic process since no acceleration in ascorbate depletion and no significant decrease in other plasma antioxidants were observed upon addition of PLPC-OOH. Cholesteryl linoleate hydroperoxide and its alcohol (Ch18:2-OH) were also detected as minor products. Similarly, 1-stearoyl-2-arachidonoylphosphatidylcholine hydroperoxide gave its alcohol (SAPC-OH) as a major product and cholesteryl arachidonate hydroperoxide and its hydroxide (Ch20:4=OH) as minor products. These oxidized cholesteryl esters are likely to be produced by the action of lecithin:cholesterol acyltransferase (LCAT) present in high-density lipoprotein (HDL) since (a) incubation of PLPC-OH and SAPC-OH in human plasma gave Ch18:2-OH and Ch20:4-OH, respectively, (b) isolated human HDL converted PLPC-OH to Ch18:2 OH and SAPC-OH to Ch20:4-OH while isolated human low-density lipoprotein was inactive for this conversion, and (c) formation of oxidized cholesteryl esters in plasma and HDL was inhibited by the LCAT inhibitor 5,5'-dithiobis(2-nitrobenzoic acid). A possible beneficial role of LCAT for converting phosphatdylcholine hydroperoxide to cholesteryl ester hydroperoxide is also discussed.
为了阐明磷脂酰胆碱氢过氧化物在人血浆中不稳定的原因,将1-棕榈酰-2-亚油酰磷脂酰胆碱氢过氧化物(PLPC-OOH)在37℃的人血浆中进行有氧孵育,并测定其分解产物。主要产物是相应的醇(PLPC-OH),这种还原可能是通过酶促过程发生的,因为加入PLPC-OOH后未观察到抗坏血酸消耗加速,也未观察到其他血浆抗氧化剂显著减少。亚油酰胆固醇氢过氧化物及其醇(Ch18:2-OH)也作为次要产物被检测到。同样,1-硬脂酰-2-花生四烯酰磷脂酰胆碱氢过氧化物产生其醇(SAPC-OH)作为主要产物,花生四烯酰胆固醇氢过氧化物及其氢氧化物(Ch20:4=OH)作为次要产物。这些氧化胆固醇酯可能是由高密度脂蛋白(HDL)中存在的卵磷脂:胆固醇酰基转移酶(LCAT)作用产生的,因为(a)PLPC-OH和SAPC-OH在人血浆中孵育分别产生Ch18:2-OH和Ch20:4-OH,(b)分离的人HDL将PLPC-OH转化为Ch18:2 OH,将SAPC-OH转化为Ch20:4-OH,而分离的人低密度脂蛋白对此转化无活性,以及(c)血浆和HDL中氧化胆固醇酯的形成受到LCAT抑制剂5,5'-二硫代双(2-硝基苯甲酸)的抑制。还讨论了LCAT将磷脂酰胆碱氢过氧化物转化为胆固醇酯氢过氧化物的可能有益作用。